| Current Price | $274.67 | Mkt Cap | $10.5B |
|---|---|---|---|
| Open | $277.59 | P/E Ratio | 0.00 |
| Prev. Close | $274.67 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $272.61 - $278.34 | Volume | 307,102 |
| 52-Wk Range | $114.87 - $283.42 | Avg. Daily Vol. | 338,483 |
| Current Price | $274.67 | Mkt Cap | $10.5B |
|---|---|---|---|
| Open | $277.59 | P/E Ratio | 0.00 |
| Prev. Close | $274.67 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $272.61 - $278.34 | Volume | 307,102 |
| 52-Wk Range | $114.87 - $283.42 | Avg. Daily Vol. | 338,483 |
The best Bull and Bear pitches based on recency and number of recommendations.
Spruce Point put out a strong sell rating. I have yet to peruse the report too much, but a quick glance at the financials for PEN did make me think that it appears to be overpriced and does not have wild growth prospects.
Read the most recent pitches from players about PEN.
Recs
volfan84
(74.27)
Submitted: 7/31/2019 2:27:08 PM :
Start Price:
$166.13
NYSE:PEN Score:
-35.06
Spruce Point put out a strong sell rating. I have yet to peruse the report too much, but a quick glance at the financials for PEN did make me think that it appears to be overpriced and does not have wild growth prospects.
Recs
TMFTypeoh
(92.41)
Submitted: 5/23/2018 11:05:32 AM :
Start Price:
$157.85
NYSE:PEN Score:
+29.33
Impressive company
Recs
DGEN4
(< 20)
Submitted: 10/19/2017 8:35:26 AM :
Start Price:
$94.90
NYSE:PEN Score:
+136.75
A very well-run company that is targeting a growing demographic and creating a new market for its neuro and vascular products. Each of its products is unique and addresses its use in a novel way. This company has performed remarkably well since its IPO in 2015 and is a longterm buy.
Find the members with the highest scoring picks in PEN.
camistocks (39.50) Score: +318.97
The Score Leader is the player with the highest score across all their picks in PEN.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
|
camistocks | 39.50 | 4/22/2016 |
|
5Y | $54.47 | +408.54% | +89.57% | +318.97 | 0 Comment |
| fivepointEmpire | 49.34 | 5/1/2017 |
|
5Y | $85.45 | +224.17% | +65.64% | +158.53 | 0 Comment | |
| DGEN4 | < 20 | 10/19/2017 |
|
5Y | $94.90 | +191.89% | +55.14% | +136.75 | 1 Comment | |
| ResearchLover | 68.59 | 7/24/2018 |
|
3Y | $140.10 | +97.72% | +40.29% | +57.42 | 0 Comment | |
| RMITRA757 | 95.07 | 7/9/2018 |
|
5Y | $142.45 | +94.45% | +42.95% | +51.50 | 0 Comment | |
| danielajpereiraa | < 20 | 3/28/2022 |
|
5Y | $205.41 | +34.85% | -12.55% | +47.40 | 0 Comment | |
| ScratchingBuy | 49.71 | 7/9/2019 |
|
5Y | $161.82 | +71.18% | +33.69% | +37.49 | 0 Comment | |
| ThePharoah | < 20 | 6/15/2018 |
|
5Y | $154.65 | +79.11% | +42.60% | +36.52 | 0 Comment | |
| TMFTypeoh | 92.41 | 5/30/2018 |
|
5Y | $157.85 | +75.48% | +46.15% | +29.33 | 1 Comment | |
| salamander1 | < 20 | 7/21/2020 |
|
5Y | $189.23 | +46.38% | +21.10% | +25.28 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
